Medical device firm St. Jude Medical has commercially introduced its Optis mobile system in Japan and Europe, developed to be used in hospitals with multiple catheterization labs.
The new diagnostic system is designed to combine modern optical coherence tomography (OCT) and angiography co-registration with fractional flow reserve (FFR) technology into one portable system.
The catheterization lab enables physicians to use minimally invasive percutaneous coronary intervention (PCI) procedures, providing patients with an alternative to open heart surgery.
Optis system helps physicians to optimize PCI procedures for the treatment of vascular disease by combining diagnostic tools designed to improve patient outcomes into one portable device.
It also enables physicians to take improved stenting decisions based on high-resolution and three dimensional OCT views of coronary anatomy while simultaneously mapping their exact location through angiogram.
The system incorporates the firm’s PressureWire FFR measurement technology, which provides physicians detailed coronary hemodynamic (circulatory) information during PCI.
St. Jude Medical group president Dr Eric Fain said: "The Optis mobile system represents the ongoing commitment of St. Jude Medical to develop products that provide physicians with more options for improved OCT and angiography co-registration guidance in their daily practice.
"In contrast with intravascular ultrasound, OCT offers increased resolution and highly-detailed intracoronary arterial views, which can improve PCI procedures, especially in complex cases."
According to St. Jude Medical, its Ilumein I and Ilumien II studies demonstrated that the firm’s OCT imaging technology can influence pre and post-PCI decision making, stent sizing and deployment.
Image: Optis mobile integrated lab. Photo: courtesy of Business Wire.